Substance Misuse Programs
in Commercial Aviation
Safety First
_____
Richard G. Frank, Dylan Rebstock, and
Melissa Welch-Ross, Editors
Committee on the Study and
Recommendations on the HIMS,
FADAP, and Other Drug and Alcohol
Programs within the USDOT
Board on Behavioral, Cognitive, and
Sensory Sciences
Division of Behavioral and Social
Sciences and Education
Transportation Research Board
Health and Medicine Division
Consensus Study Report
NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001
This activity was supported by a contract between the National Academy of Sciences and the Federal Aviation Administration (#693KA9-22-T-00002). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
International Standard Book Number-13: 978-0-309-70278-2
International Standard Book Number-10: 0-309-70278-X
Digital Object Identifier: https://doi.org/10.17226/27025
Library of Congress Control Number: 2023944913
This publication is available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
Copyright 2023 by the National Academy of Sciences. National Academies of Sciences, Engineering, and Medicine and National Academies Press and the graphical logos for each are all trademarks of the National Academy of Sciences. All rights reserved.
Printed in the United States of America.
Suggested citation: National Academies of Sciences, Engineering, and Medicine. 2023. Substance Misuse Programs in Commercial Aviation: Safety First. Washington, DC: The National Academies Press. https://doi.org/10.17226/27025.
The National Academy of Sciences was established in 1863 by an Act of Congress, signed by President Lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Members are elected by their peers for outstanding contributions to research. Dr. Marcia McNutt is president.
The National Academy of Engineering was established in 1964 under the charter of the National Academy of Sciences to bring the practices of engineering to advising the nation. Members are elected by their peers for extraordinary contributions to engineering. Dr. John L. Anderson is president.
The National Academy of Medicine (formerly the Institute of Medicine) was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues. Members are elected by their peers for distinguished contributions to medicine and health. Dr. Victor J. Dzau is president.
The three Academies work together as the National Academies of Sciences, Engineering, and Medicine to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine.
Learn more about the National Academies of Sciences, Engineering, and Medicine at www.nationalacademies.org.
Consensus Study Reports published by the National Academies of Sciences, Engineering, and Medicine document the evidence-based consensus on the study’s statement of task by an authoring committee of experts. Reports typically include findings, conclusions, and recommendations based on information gathered by the committee and the committee’s deliberations. Each report has been subjected to a rigorous and independent peer-review process, and it represents the position of the National Academies on the statement of task.
Proceedings published by the National Academies of Sciences, Engineering, and Medicine chronicle the presentations and discussions at a workshop, symposium, or other event convened by the National Academies. The statements and opinions contained in proceedings are those of the participants and are not endorsed by other participants, the planning committee, or the National Academies.
Rapid Expert Consultations published by the National Academies of Sciences, Engineering, and Medicine are authored by subject-matter experts on narrowly focused topics that can be supported by a body of evidence. The discussions contained in rapid expert consultations are considered those of the authors and do not contain policy recommendations. Rapid expert consultations are reviewed by the institution before release.
For information about other products and activities of the National Academies, please visit www.nationalacademies.org/about/whatwedo.
COMMITTEE ON THE STUDY AND RECOMMENDATIONS ON THE HIMS, FADAP, AND OTHER DRUG AND ALCOHOL PROGRAMS WITHIN THE USDOT
RICHARD G. FRANK1 (Chair), Brookings Institution
DAVID L. ALBRIGHT, University of Alabama
DANIEL N. DASILVA, Morris Psychological Group
ROBYN L. HACKER, University of Colorado
JERMAINE D. JONES, Columbia University
MADELINE H. MEIER, Arizona State University
MICHELLE N. MEYER, Geisinger Health System
KATHRYN E. NEWCOMER, George Washington University
BERNADETTE E. PHELAN, Retired, Arizona Department of Transportation
JEFFREY SELZER, New York State Committee for Physician Health
MO WANG, University of Florida
Board Liaison
TERRIE E. MOFFITT,2 Duke University
Study Staff
DYLAN REBSTOCK, Study Director
MELISSA WELCH-ROSS, Senior Program Officer
LYLE CARRERA, Research Associate
JACQUELINE L. COLE, Senior Program Assistant
MEGAN SNAIR, Science Writer
YNGVILD OLSEN, Consultant
___________________
1 Member, National Academy of Medicine
2 Member, National Academy of Medicine
NOTE: See Appendix E, Disclosure of Unavoidable Conflict of Interest.
BOARD ON BEHAVIORAL, COGNITIVE, AND SENSORY SCIENCES
TERRIE E. MOFFITT1 (Chair), Duke University
RICHARD N. ASLIN,2 Haskins Laboratories
JOHN BAUGH, Washington University, St. Louis
WILSON S. GEISLER, The University of Texas at Austin
MICHELE J. GELFAND, Stanford Graduate School of Business
ULRICH MAYR, University of Oregon
KATHERINE L. MILKMAN, The University of Pennsylvania
ELIZABETH A. PHELPS, Harvard University
DAVID E. POEPPEL, New York University
STACEY SINCLAIR, Princeton University
TIMOTHY J. STRAUMAN, Duke University
DANIEL J. WEISS, Director
___________________
1 Member, National Academy of Medicine
2 Member, National Academy of Science
Reviewers
This Consensus Study Report was reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise. The purpose of this independent review is to provide candid and critical comments that will assist the National Academies of Sciences, Engineering, and Medicine in making each published report as sound as possible and to ensure that it meets the institutional standards for quality, objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confidential to protect the integrity of the deliberative process.
We thank the following individuals for their review of this report:
RICHARD N. ASLIN, Yale University
JONATHAN P. CAULKINS, Carnegie Mellon University
NICOLE ENNIS, Florida State University
CHRISTIAN HOPFER, University of Colorado Anschutz Medical Campus
DENNIS MCCARTY, Oregon Health & State University
JOSIAH D. RICH, Miriam Hospital, Brown University
PAUL M. ROMAN, University of Georgia
CHRISTINE TIMKO, U.S. Department of Veterans Affairs
EUGENIA VASQUEZ, University of Colorado
Although the reviewers listed above provided many constructive comments and suggestions, they were not asked to endorse the conclusions or recommendations of this report nor did they see the final draft before its release. The review of this report was overseen by ROBERT WALLACE,
University of Iowa, and HORTENSIA AMARO, Florida International University. They were responsible for making certain that an independent examination of this report was carried out in accordance with the standards of the National Academies and that all review comments were carefully considered. Responsibility for the final content rests entirely with the authoring committee and the National Academies.
Acknowledgments
This report reflects contributions from a number of individuals and groups. The committee takes this opportunity to recognize those who so generously gave their time and expertise to inform its deliberations.
To begin, the committee would like to thank the Federal Aviation Administration and the Office of Senator Jeanne Shaheen for their sponsorship, guidance, and support of this study.
The committee greatly benefited from the opportunity for discussion with individuals who attended and presented at the open session meetings or provided written testimony: Kip Bowen, David Fielding, Heather Healy, Suzanne Kalfus, Andrew LeBovidge, Rick Mahoney, Tom McLellan, Pat Moy, Billy Petersen, Sarah Polk, Jerry Powers, Bryan Price, Iyon Rosario, Quay Snyder, David St. Helaire, and Nora Volkow.
The committee thanks these individuals for their time and the candid perspectives they provided.
The committee could not have done its work without the support and guidance provided by the National Academies of Sciences, Engineering, and Medicine project staff: Dylan Rebstock, Study Director; Melissa Welch-Ross, Senior Program Officer; Lyle Carrera, Research Associate; and Jacqueline L. Cole, Senior Program Assistant. We appreciate Patrick Burke for his financial assistance on this project and gratefully acknowledge Daniel J. Weiss of the National Academies’ Board on Behavioral, Cognitive, and Sensory Sciences for his guidance.
Many other staff within the National Academies provided support to this project in various ways. The committee would like to thank Samantha Chao, Connie Citro, Chris King, Sandy McDermin, Tom Menzies, Sharyl
Nass, Kirsten Sampson Snyder, and Jeanne Rivard for their expertise and support throughout the life cycle of this research study and report.
This committee is grateful to the research assistants and commissioned paper authors who generously contributed to this body of work: Heather Belanger, Anne Marie Houppert, Gary Kay, Christopher Lao-Scott, Cara Nordberg, and Jennifer Wisdom.
In addition to the contributions above, a great number of stakeholders offered resources, expertise, and insight to support the committee’s work.
Contents
Identification of People in Need of Treatment
The Role of FADAP and HIMS in the Ecology of Aviation Safety and Healthcare
Heavy Reliance on Inpatient and Residential Treatment Modalities
HIMS and FADAP Make Strong Assertions for Their Successes
REGULATORY CONTEXT: SUBSTANCE MISUSE PROGRAMS IN THE AVIATION SECTOR
Definitions and Sources of Information
Treatment Service Delivery Process
Employee Return-to-Duty Procedure
Program Monitoring and Outcomes Measurement
3 Evidence-Based Practices for Identifying and Treating Substance Use Disorders
OVERVIEW OF SUBSTANCE USE DISORDERS
Diagnostic Criteria for Substance Use Disorders
Benefits of Prevention and Early Intervention
Integrating Approaches to Improve Care
BEST PRACTICES IN SCREENING, ASSESSING, AND TREATING SUBSTANCE USE DISORDERS
Assessment of Substance Use Disorders
Treatment of Substance Use Disorders Across a Continuum of Care
ONGOING HEALTH STATUS MONITORING AND TESTING
Individualized Care and Required Length of Stay
Pilots and Medication for Addiction Treatment
Leveraging Mutual Help Groups in Recovery
FACTORS THAT FACILITATE OR IMPEDE PILOTS AND FLIGHT ATTENDANTS FROM SEEKING TREATMENT WHEN NEEDED
KEY ELEMENTS OF GOOD SUBSTANCE USE DISORDER TREATMENT FOR PILOTS AND FLIGHT ATTENDANTS
Findings from an Independent Analysis of the FADAP Database
Agreement of Findings: A Comparison Between FADAP Annual Reports and the Independent Analysis
Findings from the “Call for Perspectives” and Qualitative Interviews
Findings from the HIMS Database
Findings from the “Call for Perspectives” and Qualitative Interviews
6 Summary Assessment: Conclusions and Recommendations
ALIGNING SUBSTANCE USE DISORDER PRACTICES AND POLICIES FOR HIMS AND FADAP WITH THE EVIDENCE BASE
Diagnosis and Case Identification
Barriers to Early Help Seeking and Access to Affordable Treatment
Allowances and Encouragement for Individual Treatment
Use of Evidence-Based Criteria in the Selection of Treatment Programs
QUALITY OF DATA AND DATA ANALYSIS FOR PROGRAM MANAGEMENT AND DECISION-MAKING
Boxes, Figures, and Tables
BOXES
3-1 Disease Model of Addiction
3-3 Categories of Stigma Toward Individuals with Substance Use Disorders
4-1 Five Important Aspects of a Safety Culture
4-2 Key Elements for Good Monitoring and Evaluation for HIMS and FADAP
6-1 Committee-Identified Key Features of Evidence-Based Practices
FIGURES
2-5 Greatment service delivery process through FADAP
3-3 Six dimensions of multidimensional assessment
4-1 The context for facilitating pilot well-being and job performance
4-2 The context for facilitating flight attendant well-being and job performance
4-3 What makes for an “effective” intervention?
A-1 Violations reported to FMCSA clearinghouse since January 6, 2020
TABLES
3-1 Heavy Alcohol Use for Men and Women
3-2 Levels of Addiction Treatment
4-1 Adherence to Recommended Practices—Considerations for HIMS and FADAP
5-2 Characteristics of 1,196 Unique Flight Attendants Who Took Part in FADAP
5-3 Treatment-Provider-Reported Treatment Details for the 1,172 FADAP Treatment Episodes
5-5 HIMS Pilots’ Ages and Relapse Rates by Age
5-6 HIMS Pilots’ Substance of Choice and Relapse Rates by Substance of Choice
A-1 Drug and Alcohol Referrals, Refusals, and Violations, 2017–2021
Acronyms and Abbreviations
AA | Alcoholics Anonymous |
AFA-CWA | Association of Flight Attendants-CWA |
ALPA | Air Line Pilots Association, International |
AME | aviation medical examiner |
ASAM | American Society of Addiction Medicine |
CDLs | commercial driving licenses |
CFR | Code of Federal Regulations |
CMVs | commercial motor vehicles |
DAC | drug and alcohol counselor |
DOT | U.S. Department of Transportation |
DSM-5 | Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition |
DSM-5-TR | Text Revision of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition |
DUI | driving under the influence |
EAP | Employee Assistance Program |
FAA | Federal Aviation Administration |
FADAP | Flight Attendant Drug and Alcohol Program |
FMCSA | Federal Motor Carrier Safety Administration |
FRA | Federal Railroad Administration |
FTA | Federal Transit Administration |
HHS | U.S. Department of Health and Human Services |
HIMS | Human Intervention and Motivational Study |
HIMS AME | Human Intervention and Motivational Study-trained aviation medical examiner |
IOP | intensive outpatient program |
LOS | length of stay |
MAT | medication-assisted treatment |
MAUD | medications for alcohol use disorder |
MHGs | mutual help groups |
MOUD | medications for opioid use disorder |
NA | Narcotics Anonymous |
NIAAA | National Institute on Alcohol Abuse and Alcoholism |
NTSB | National Transportation Safety Board |
OTC | over-the-counter |
OTP | opioid treatment program |
P&P | [HIMS-trained] psychiatrist and neuropsychologist |
PHPs | Physician Health Programs |
ROI | release of information |
SAMHSA | Substance Abuse and Mental Health Services Administration |
SAP | substance abuse professional |
SBIRT | screening, brief intervention, and referral to treatment |
WHO | World Health Organization |
XR-naltrexone | extended-release injectable naltrexone |